Neuroscience

After epilepsy setback, Ovid charges confidently ahead in CNS
Pharma Voice
Fri, 09/20/24 - 10:27 am
Ovid Therapeutics
R&D
Neuroscience
Takeda
Don’t call it a comeback: Biotech’s CNS resurgence forges Big Pharma connections
Pharma Voice
Fri, 06/28/24 - 11:17 am
Big Pharma
Neuroscience
Prothena Biosciences
Biogen
Eisai
Pfizer
AbbVie
Eli Lilly
Bristol Myers Squibb
Alkermes and Jazz: Two Different Approaches to Neuroscience, Oncology Portfolios
BioSpace
Tue, 03/12/24 - 11:02 am
Alkermes
Jazz Pharma
Neuroscience
oncology
Cancer and Neuroscience Led 2023 VC, M&A Investment in Biopharma
BioSpace
Wed, 02/14/24 - 11:36 am
funding
M&A
venture capital
cancer
Neuroscience
AI, Neuroscience and GLP-1s Will Maintain Momentum: Expert Panel
BioSpace
Tue, 01/9/24 - 10:00 pm
biotech
artificial intelligence
GLP-1 agonist
Neuroscience
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
AbbVie
Cerevel Therapeutics
M&A
Neuroscience
As J&J outlines bullish pipeline goals, neuroscience pipeline takes a starring role
Fierce Biotech
Wed, 12/6/23 - 09:15 pm
JNJ
Neuroscience
Spravato
major depressive disorder
Immuneering takes aim at cancer’s ‘superhighway’
Pharma Voice
Mon, 09/11/23 - 06:50 pm
Immuneering
Neuroscience
cancer
oncology
RAS
2 Things About AbbVie That Investors Are Ignoring
Motley Fool
Wed, 05/3/23 - 10:34 pm
AbbVie
immunology
aesthetics
Neuroscience
Novartis Culls 10% of Pipeline, Doubles Down on Five Core Therapeutic Areas
BioSpace
Wed, 04/26/23 - 10:24 am
Novartis
earnings
solid tumors
hematology
immunology
Neuroscience
cardiovascular disease
J&J-backed startup launches with $100M to build better brain drugs
BioPharma Dive
Tue, 03/7/23 - 11:14 am
Rapport Therapeutics
JNJ
Neuroscience
neurological disorders
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer's and depression prospect
Fierce Biotech
Tue, 03/1/22 - 10:42 am
AbbVie
M&A
Neuroscience
Syndesi Therapeutics
UCB Pharma
Alzheimer's disease
depression
Roche Signs Machine-Learning Neuroscience Deal With Recursion
Bloomberg
Tue, 12/7/21 - 10:53 am
Roche
Genentech
artificial intelligence
machine learnings
Recursion Pharmaceuticals
cancer
Neuroscience
Lilly, with Alzheimer's in its crosshairs, forms new neuroscience unit, unifies oncology under Loxo exec
Fierce Biotech
Tue, 08/17/21 - 10:26 am
Eli Lilly
reorganization
Loxo Oncology
oncology
Neuroscience
Alzheimer's disease
Genentech teams with academics for 10-year neuroscience R&D push
Fierce Biotech
Sun, 02/28/21 - 10:12 pm
Genentech
R&D
Neuroscience
5 trends in biotech dealmaking to watch in 2021
BioPharma Dive
Wed, 01/13/21 - 11:37 pm
biotech
Neuroscience
SPAC
Big Pharma
private equity
Novartis acquires a small biotech and its trio of brain drugs
BioPharma Dive
Thu, 12/17/20 - 11:57 am
Novartis
M&A
Cadent
Neuroscience
Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup
Endpoints
Tue, 12/1/20 - 10:46 am
startups
Neuroscience
psychiatry
Roche
Noema
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Wed, 01/29/20 - 11:55 pm
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs
Xconomy
Fri, 01/10/20 - 10:18 am
Biogen
Neuroscience
CAMP4 Therapeutics
drug development

Pages